C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Takes $2.54 Million Position in Chemed Co. (NYSE:CHE)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Chemed Co. (NYSE:CHEFree Report) in the fourth quarter, Holdings Channel.com reports. The firm bought 4,794 shares of the company’s stock, valued at approximately $2,540,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. CIBC Asset Management Inc boosted its stake in Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares during the period. EP Wealth Advisors LLC boosted its stake in Chemed by 1.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after purchasing an additional 25 shares during the period. Ballentine Partners LLC boosted its stake in Chemed by 4.1% during the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after purchasing an additional 26 shares during the period. First Heartland Consultants Inc. boosted its stake in Chemed by 7.2% during the 3rd quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock valued at $305,000 after purchasing an additional 34 shares during the period. Finally, First Trust Direct Indexing L.P. boosted its stake in Chemed by 4.5% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock valued at $533,000 after purchasing an additional 38 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.32% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CHE shares. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Read Our Latest Research Report on CHE

Chemed Trading Down 0.7 %

CHE stock opened at $549.97 on Wednesday. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The company has a market capitalization of $8.28 billion, a price-to-earnings ratio of 27.79, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48. The firm’s 50-day moving average is $542.45 and its two-hundred day moving average is $564.40.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed’s payout ratio is currently 10.11%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.